DAWN HALKUFF

Insider Reports History

Location
Chicago, IL
Signature
/s/ Beth Hecht, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by DAWN HALKUFF:

Company Role Class Num Shares Value Price $ Report Date Ownership
Xeris Biopharma Holdings, Inc. Director Common Stock 115,000 $836,728 $7.28 12 Aug 2025 Direct
Xeris Biopharma Holdings, Inc. Director Common Stock 5,410 $25,264 $4.67 12 Aug 2025 By; DAWN HALKUFF REVOCABLE TRUST U/A DTD 08/25/2017
XERIS PHARMACEUTICALS INC Director Stock Option (Right to Buy) 0 05 Oct 2021 Direct

Insider Reports Filed by DAWN HALKUFF

Symbol Company Period Transactions Value $ Form Type Role Filing Time
XERS Xeris Biopharma Holdings, Inc. 12 Aug 2025 1 -$309,226 4 Director 13 Aug 2025, 16:47
XERS Xeris Biopharma Holdings, Inc. 04 Jun 2025 1 $0 4 Director 04 Jun 2025, 19:03
XERS Xeris Biopharma Holdings, Inc. 05 Jun 2024 1 $0 4 Director 05 Jun 2024, 16:18
XERS Xeris Biopharma Holdings, Inc. 20 Nov 2023 1 +$9,954 4 Director 21 Nov 2023, 16:20
XERS Xeris Biopharma Holdings, Inc. 07 Jun 2023 1 $0 4 Director 07 Jun 2023, 16:58
XERS Xeris Biopharma Holdings, Inc. 08 Jun 2022 2 $0 4 Director 09 Jun 2022, 17:14
XERS Xeris Biopharma Holdings, Inc. 05 Oct 2021 4 $0 4 Director 05 Oct 2021, 19:51
XERS XERIS PHARMACEUTICALS INC 05 Oct 2021 4 $0 4 Director 05 Oct 2021, 17:37
XERS Xeris Biopharma Holdings, Inc. 05 Oct 2021 0 $0 3 Director 05 Oct 2021, 17:16
XERS XERIS PHARMACEUTICALS INC 08 Jun 2021 1 $0 4 Director 08 Jun 2021, 19:09